p to drug exposure.
Hypersensitivity reactions include anaphylaxis, angioedema, rash, urticaria, and exfoliative skin conditions including Stevens-Johnson syndrome [see Warnings and Precautions (5.3); hepatic enzyme elevations.
There was a slight increase in the area under the curve (AUC, 11%) and mean peak drug concentration (Cmax, 18%) of digoxin with the co-administration of 100mg sitagliptin for 10 days. Patients receiving digoxin should be monitored appropriately. No dosage adjustment of digoxin or JANUVIA is recommended.
- USE IN SPECIFIC POPULATIONS
Pregnancy CategoryB:
Reproduction studies have been performed in rats and rabbits. Doses of sitagliptin up to 125mg/kg (approximately 12 times the human exposure at the maximum recommended human dose) did not impair fertility or harm the fetus. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Merck & Co., Inc. maintains a registry to monitor the pregnancy outcomes of women exposed to JANUVIA while pregnant. Health care providers are encouraged to report any prenatal exposure to JANUVIA by calling the Pregnancy Registry at (800) 986-8999.
Sitagliptin administered to pregnant female rats and rabbits from gestation day 6 to 20 (organogenesis) wa
'/>"/>
Source: PRWeb Copyright©2008 Vocus, Inc. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 Related medicine news :1.
STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses2.
Landmark study defines benefits of early HIV testing and treatment for infected infants3.
Study identifies causes of bone loss in breast cancer survivors4.
New Study by BioTrends Highlights Practice Management Shifts Among Canadian Nephrologists5.
Study Suggests Need for More Aggressive Outpatient Monitoring of Patients Hearts When Cause of Stroke is Unclear6.
Rutgers researchers study cites media violence as critical risk factor for aggression7.
Brigham and Womens Researchers Partner with Vocantas to use CallAssure in Clinical Research Study8.
Analyst Available to Comment on New JUPITER Study That Shows AstraZenecas Crestor Significantly Reduces CV Risk9.
New Study Finds CO2 Ablative Fractional Resurfacing Safe And Effective For Deep Acne Scarring10.
Study investigates Gore-tex-type device to stop strokes and mini-strokes11.
The smart way to study